Chemoinformaics analysis of 11-Dodecen-1-ol
| Molecular Weight | 184.323 | nRot | 10 |
| Heavy Atom Molecular Weight | 160.131 | nRig | 1 |
| Exact Molecular Weight | 184.183 | nRing | 0 |
| Solubility: LogS | -4.074 | nHRing | 0 |
| Solubility: LogP | 4.376 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 36.845 |
| nHD | 1 | BPOL | 24.077 |
| QED | 0.405 |
| Synth | 1.974 |
| Natural Product Likeliness | 1.071 |
| NR-PPAR-gamma | 0.075 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.011 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.582 |
| MDCK | 0.0000241 |
| BBB | 0.995 |
| PPB | 0.924329 |
| VDSS | 1.029 |
| FU | 0.0694603 |
| CYP1A2-inh | 0.818 |
| CYP1A2-sub | 0.259 |
| CYP2c19-inh | 0.396 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.264 |
| CYP2c9-sub | 0.892 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.333 |
| CYP3a4-inh | 0.315 |
| CYP3a4-sub | 0.093 |
| CL | 7.439 |
| T12 | 0.417 |
| hERG | 0.045 |
| Ames | 0.012 |
| ROA | 0.039 |
| SkinSen | 0.954 |
| Carcinogencity | 0.086 |
| EI | 0.982 |
| Respiratory | 0.285 |
| NR-Aromatase | 0.024 |
| Antiviral | No |
| Prediction | 0.536767 |